Striving for Patient-Centered Diabetes Care
The pandemic has forced many Americans to re-examine their approach to life’s challenges and identify ways to be more efficient in changing times. The same should apply to treating people who live with diabetes.
Gout Patients’ Hidden Heart Risk
Joints become red, swollen and painful. For people with gout, these are telltale signs of an attack. But research suggests gout patients should also watch for signs of another event – a heart attack.
Time to End Insurer-Driven Rx Switches
For too long, patients have been getting bumped off their physician-prescribed medication in favor of a different medication – one preferred by their insurance company.
A Map to Hepatitis Elimination
After years of steadily increasing hepatitis rates, the country has lost its way on controlling the deadly viral disease. Now, it has a new map.
Telehealth Isn’t Only for Pandemics
I was 15 when I was diagnosed with two rare liver diseases. Growing up in rural Kentucky, that meant countless out of state trips to see specialists. Those trips were a family commitment.
Cancer Innovations Worth Celebrating
Last year was a downer in so many ways. But, for the oncology community, 2020 also brought plenty of reasons to celebrate.
America’s Spectrum of Support for Patients
Americans “Go Red” in February for heart disease awareness and paint the town pink every October in honor of breast cancer patients. These celebrations are a stark contrast, however, to the public’s response to some health conditions.
How Pregnant Moms Can Make Every Bite Count
“Make Every Bite Count” is the theme of the recently released Dietary Guidelines for Americans.
Drug Shortage Distress
With the nation’s attention riveted on the distribution of COVID-19 vaccines, drugs that allow patients to deal with other serious medical conditions are falling by the wayside.
Lacks’ Law Pursues Diversity in Cancer Clinical Trials
As the nation prepared for the 46th presidential inauguration, a piece of legislation that could help solve a major problem in clinical research was quietly signed into law.
